2024
Prescription Drug Prices: An AAN Position Statement.
Santoro J, Sico J, Burke J, Sarkar K, Turbes M, Evans D, Jordan J. Prescription Drug Prices: An AAN Position Statement. Neurology 2024, 102: e209132. PMID: 38335469, DOI: 10.1212/wnl.0000000000209132.Peer-Reviewed Original ResearchConceptsHigh cost of medicationNeurological disordersDevelopment of novel therapeuticsNeurological diseasesOrphan Drug ActTherapeutic optionsCost of medicationsHigh-value careCost of prescription drugsPrescription drug pricesRare diseaseTreat rare diseasesPatientsNovel therapeuticsTreat neurological disordersDrug ActCost containment effortsChronic neurological conditionsEffective prescription medicationsMedicationPrescriber accessPrescription medicationsTherapyHealthcare systemApproval pathway
2020
Implementation Evaluation of a Complex Intervention to Improve Timeliness of Care for Veterans with Transient Ischemic Attack
Damush T, Miech E, Rattray N, Homoya B, Penney L, Cheatham A, Baird S, Myers J, Austin C, Myers L, Perkins A, Zhang Y, Giacherio B, Kumar M, Murphy L, Sico J, Bravata D. Implementation Evaluation of a Complex Intervention to Improve Timeliness of Care for Veterans with Transient Ischemic Attack. Journal Of General Internal Medicine 2020, 36: 322-332. PMID: 33145694, PMCID: PMC7878645, DOI: 10.1007/s11606-020-06100-w.Peer-Reviewed Original ResearchConceptsTransient ischemic attackIschemic attackClinical improvementStepped-wedge implementation trialQI teamsGuideline-concordant careTimeliness of careQuality improvement interventionsVA healthcare systemComplex quality improvement interventionsPrimary outcomeTeam activationImplementation strategiesKey implementation strategiesImplementation trialImprovement interventionsClinical staffComplex interventionsConsolidated FrameworkQI programQI planExternal facilitationImplementation researchHealthcare systemPoint improvement